| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-01-27 | SCHEDULE | Frazier Life Sciences IX, L.P. | 6.80% | 4,108,404 | view → |
| 2020-12-22 | SC | RiverVest Venture Fund IV, L.P. | — | — | view → |
| 2020-12-18 | SC | Frazier Life Sciences IX, L.P. | — | — | view → |
| 2020-12-18 | SC | Novo Holdings A/S | — | — | view → |
| 2020-04-29 | SC | Frazier Life Sciences IX, L.P. | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-01-23 | SCHEDULE | IO Biotech, Inc. IOBTQ | 3.30% | 2,469,135 | view → |
| 2025-01-16 | SCHEDULE | Galecto, Inc. DMRA | 7.60% | 99,913 | view → |
| 2024-01-02 | SC | Rallybio Corp RLYB | — | — | view → |
| 2022-10-03 | SC | LAVA Therapeutics NV | — | — | view → |
| 2022-07-15 | SC | Bolt Biotherapeutics, Inc. BOLT | — | — | view → |
| 2022-02-22 | SC | Morphic Holding, Inc. | — | — | view → |
| 2022-01-27 | SC | Reneo Pharmaceuticals, Inc. OKUR | — | — | view → |
| 2021-12-20 | SC | Cyteir Therapeutics, Inc. | — | — | view → |
| 2021-11-22 | SC | Nkarta, Inc. NKTX | — | — | view → |
| 2021-11-22 | SC | Bolt Biotherapeutics, Inc. BOLT | — | — | view → |
| 2021-11-22 | SC | SPRUCE BIOSCIENCES, INC. SPRB | — | — | view → |
| 2021-08-12 | SC | Morphic Holding, Inc. | — | — | view → |
| 2021-06-21 | SC | Aligos Therapeutics, Inc. ALGS | — | — | view → |
| 2021-05-21 | SC | SPRUCE BIOSCIENCES, INC. SPRB | — | — | view → |
| 2021-03-30 | SC | Inozyme Pharma, Inc. | — | — | view → |
| 2021-03-11 | SC | Morphic Holding, Inc. | — | — | view → |
| 2021-02-01 | SC | Inozyme Pharma, Inc. | — | — | view → |
| 2020-12-18 | SC | Mirum Pharmaceuticals, Inc. MIRM | — | — | view → |
| 2020-10-05 | SC | Inozyme Pharma, Inc. | — | — | view → |
| 2020-07-24 | SC | Verona Pharma plc | — | — | view → |
Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.
Request a pilot →